Evidence map›Paper›PMID 35481626›Full record

ArticleESC heart failure2022

Potential efficacy of multipoint pacing in the reduction of mitral regurgitation volume: a case report.

Masato Wada, Hidekazu Kondo, Tomoko Fukuda, Hiroki Sato, Hirochika Yamasaki, Keisuke Yonezu, Tetsuya Uemura, Naoko Ogawa, Shotaro Saito, Takashi Shuto and 5 more

Open access · goldAbstract readCase Reports
In one paragraph

Article in ESC heart failure, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.3field-weighted citation impact, top 42% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 2 citations in OpenAlex.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 2 institutions in 2 countries.

Masato WadaDepartment of Cardiology and Clinical Examination, Faculty of Medicine, Oita University, Yufu, Japan.
Hidekazu KondoDepartment of Cardiology and Clinical Examination, Faculty of Medicine, Oita University, Yufu, Japan.ORCID 0000-0003-2451-5845
Tomoko FukudaDepartment of Cardiology and Clinical Examination, Faculty of Medicine, Oita University, Yufu, Japan.
Hiroki SatoDepartment of Internal Medicine, Kunisaki City Hospital, Kunisaki, Japan.
Hirochika YamasakiDepartment of Cardiology and Clinical Examination, Faculty of Medicine, Oita University, Yufu, Japan.
Keisuke YonezuDepartment of Cardiology and Clinical Examination, Faculty of Medicine, Oita University, Yufu, Japan.
Tetsuya UemuraDepartment of Cardiology and Clinical Examination, Faculty of Medicine, Oita University, Yufu, Japan.
Naoko OgawaDepartment of Cardiology and Clinical Examination, Faculty of Medicine, Oita University, Yufu, Japan.
Shotaro SaitoDepartment of Cardiology and Clinical Examination, Faculty of Medicine, Oita University, Yufu, Japan.
Takashi ShutoDepartment of Cardiovascular Surgery, Faculty of Medicine, Oita University, Yufu, Japan.
Tomoyuki WadaDepartment of Cardiovascular Surgery, Faculty of Medicine, Oita University, Yufu, Japan.
Kunio YufuDepartment of Cardiology and Clinical Examination, Faculty of Medicine, Oita University, Yufu, Japan.
Seiki NobeDepartment of Internal Medicine, Kunisaki City Hospital, Kunisaki, Japan.
Shinji MiyamotoDepartment of Cardiovascular Surgery, Faculty of Medicine, Oita University, Yufu, Japan.
Naohiko TakahashiDepartment of Cardiology and Clinical Examination, Faculty of Medicine, Oita University, Yufu, Japan.
Oita University · JPKunming Third People's Hospital · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

A 70-year-old woman who had cardiac sarcoidosis and severe tethering mitral regurgitation (MR) and had been implanted with a biventricular pacemaker experienced recurrent hospitalisation due to decompensated heart failure (HF). Application of MultiPoint™ pacing reduced the MR volume and maintained the symptoms under control; however, the predicted longevity of the device significantly decreased because of the very high threshold of the added pacing site. Transcatheter mitral valve repair (TMVR) using MitraClip® was performed to further diminish the severe MR, thereby enabling the switch from highly consumptive multipoint pacing (MPP) to energy-saving single-point pacing. MPP could further reduce MR compared to the conventional single-point pacing, and this could be a bridging therapy to TMVR in some patients implanted with a biventricular pacemaker. This is the first case to report that switching from conventional single-point pacing to MPP decreased the MR, to some extent, resulting in the improvement of HF symptoms.

Indexed as

Cardiac Surgical ProceduresHeart FailureMitral Valve InsufficiencyPacemaker, ArtificialAgedFemaleHospitalizationHumansHeart failureMitral regurgitationMultipoint pacingTranscatheter mitral valve repair

Identifiers

PMID35481626
PMCPMC9288779
OpenAlexW4225093816

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.